|
|
||||||||
The Journal of Immunology, Vol 150, Issue 10 4659-4671, Copyright © 1993 by American Association of Immunologists
ARTICLES |
R Nayersina, P Fowler, S Guilhot, G Missale, A Cerny, HJ Schlicht, A Vitiello, R Chesnut, JL Person and AG Redeker
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.
Inasmuch as the hepatitis B virus (HBV) is not directly cytopathic for the infected hepatocyte, it is generally presumed that viral clearance and liver cell injury during viral hepatitis are due to a CTL response to HBV encoded Ag presented by HLA class I molecules. We have previously examined the peripheral blood CTL response to two HBV nucleocapsid epitopes in patients with acute and chronic viral hepatitis, one of which is restricted by HLA-A2, whereas the other is dually restricted by HLA-A31 and Aw68. In this study, we defined the HLA-A2-restricted CTL response to the hepatitis B surface Ag (HBsAg) by using a panel of HBsAg-derived synthetic peptides containing the ideal HLA-A2.1 binding motif (-L------V). Several novel aspects of HBV immunobiology and pathogenesis are evident from this study. First, the peripheral blood CTL response to HBV-encoded Ag is remarkably polyclonal and multispecific in most patients with acute hepatitis. Indeed, HLA-A2-restricted CTL specific for as many as four envelope epitopes and one nucleocapsid epitope were found to be present simultaneously in individual patients with acute viral hepatitis. Second, HBV-specific CTL are not detectable in the peripheral blood in a minority of patients with acute hepatitis, nor have we detected a CTL response in any of the patients with chronic hepatitis that we have studied thus far. Although the cellular and molecular basis for CTL nonresponse remains to be determined, the data suggest that it may contribute to viral persistence. Third, the diversity and the specificity of the CTL response is determined in part by the coding sequence of the viral genome present in each infected patient. Indeed, the apparent nonresponse of some acutely infected patients to at least one HBsAg-specific CTL epitope actually reflects infection by a viral variant that contains a critical substitution in one of the anchor residues within the epitope. Finally, at a fundamental level, the data suggest that the presence of the HLA-A2.1-binding motif in a peptide may not be sufficient for binding; and the capacity of a peptide to bind the class I molecule does not guarantee that it will be immunogenic.
This article has been cited by other articles:
![]() |
A. T. Tan, E. Loggi, C. Boni, A. Chia, A. J. Gehring, K. S. R. Sastry, V. Goh, P. Fisicaro, P. Andreone, C. Brander, et al. Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire J. Virol., November 15, 2008; 82(22): 10986 - 10997. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Stoffels and H. G. Spencer An Asymmetric Model of Heterozygote Advantage at Major Histocompatibility Complex Genes: Degenerate Pathogen Recognition and Intersection Advantage Genetics, March 1, 2008; 178(3): 1473 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Depla, A. Van der Aa, B. D. Livingston, C. Crimi, K. Allosery, V. De Brabandere, J. Krakover, S. Murthy, M. Huang, S. Power, et al. Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections J. Virol., January 1, 2008; 82(1): 435 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mancini-Bourgine, F. Bayard, P. Soussan, Q. Deng, Y.-C. Lone, D. Kremsdorf, and M.-L. Michel Hepatitis B Virus Splice-Generated Protein Induces T-Cell Responses in HLA-Transgenic Mice and Hepatitis B Virus-Infected Patients J. Virol., May 15, 2007; 81(10): 4963 - 4972. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boni, P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, et al. Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection J. Virol., April 15, 2007; 81(8): 4215 - 4225. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Robek, M. L. Garcia, B. S. Boyd, and F. V. Chisari Role of Immunoproteasome Catalytic Subunits in the Immune Response to Hepatitis B Virus J. Virol., January 15, 2007; 81(2): 483 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bertoletti and A. J. Gehring The immune response during hepatitis B virus infection J. Gen. Virol., June 1, 2006; 87(6): 1439 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-P. Woo, T. Doan, K. A. Herd, H.-J. Netter, and R. W. Tindle Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes. J. Virol., April 1, 2006; 80(8): 3975 - 3984. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Riedl, A. Bertoletti, R. Lopes, F. Lemonnier, J. Reimann, and R. Schirmbeck Distinct, Cross-Reactive Epitope Specificities of CD8 T Cell Responses Are Induced by Natural Hepatitis B Surface Antigen Variants of Different Hepatitis B Virus Genotypes J. Immunol., April 1, 2006; 176(7): 4003 - 4011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Murray, S. F. Wieland, R. H. Purcell, and F. V. Chisari Dynamics of hepatitis B virus clearance in chimpanzees PNAS, December 6, 2005; 102(49): 17780 - 17785. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Wieland and F. V. Chisari Stealth and Cunning: Hepatitis B and Hepatitis C Viruses J. Virol., August 1, 2005; 79(15): 9369 - 9380. [Full Text] [PDF] |
||||
![]() |
S. F. Wieland, A. Eustaquio, C. Whitten-Bauer, B. Boyd, and F. V. Chisari Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids PNAS, July 12, 2005; 102(28): 9913 - 9917. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Hutchings, S. C. Gilbert, A. V. S. Hill, and A. C. Moore Novel Protein and Poxvirus-Based Vaccine Combinations for Simultaneous Induction of Humoral and Cell-Mediated Immunity J. Immunol., July 1, 2005; 175(1): 599 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mizukoshi, J. Sidney, B. Livingston, M. Ghany, J. H. Hoofnagle, A. Sette, and B. Rehermann Cellular Immune Responses to the Hepatitis B Virus Polymerase J. Immunol., November 1, 2004; 173(9): 5863 - 5871. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. M. Webster, S. Reignat, D. Brown, G. S. Ogg, L. Jones, S. L. Seneviratne, R. Williams, G. Dusheiko, and A. Bertoletti Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy J. Virol., June 1, 2004; 78(11): 5707 - 5719. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Wang, H.-C. Wu, C.-F. Chen, N. Fausto, H.-Y. Lei, and I.-J. Su Different Types of Ground Glass Hepatocytes in Chronic Hepatitis B Virus Infection Contain Specific Pre-S Mutants that May Induce Endoplasmic Reticulum Stress Am. J. Pathol., December 1, 2003; 163(6): 2441 - 2449. [Abstract] [Full Text] |
||||
![]() |
T Imamura, O Yokosuka, T Kurihara, T Kanda, K Fukai, F Imazeki, and H Saisho Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan Gut, November 1, 2003; 52(11): 1630 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Loirat, M. Mancini-Bourgine, J.-P. Abastado, and M.-L. Michel HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection Int. Immunol., October 1, 2003; 15(10): 1125 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Urbani, C. Boni, G. Missale, G. Elia, C. Cavallo, M. Massari, G. Raimondo, and C. Ferrari Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C J. Virol., November 13, 2002; 76(24): 12423 - 12434. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kakimi, M. Isogawa, J. Chung, A. Sette, and F. V. Chisari Immunogenicity and Tolerogenicity of Hepatitis B Virus Structural and Nonstructural Proteins: Implications for Immunotherapy of Persistent Viral Infections J. Virol., July 29, 2002; 76(17): 8609 - 8620. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alexander, C. Oseroff, C. Dahlberg, M. Qin, G. Ishioka, M. Beebe, J. Fikes, M. Newman, R. W. Chesnut, P. A. Morton, et al. A Decaepitope Polypeptide Primes for Multiple CD8+ IFN-{gamma} and Th Lymphocyte Responses: Evaluation of Multiepitope Polypeptides as a Mode for Vaccine Delivery J. Immunol., June 15, 2002; 168(12): 6189 - 6198. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kita, Z.-X. Lian, J. Van de Water, X.-S. He, S. Matsumura, M. Kaplan, V. Luketic, R. L. Coppel, A. A. Ansari, and M. E. Gershwin Identification of HLA-A2-restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis: T Cell Activation Is Augmented by Immune Complexes Cross-Presented by Dendritic Cells J. Exp. Med., January 7, 2002; 195(1): 113 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Thimme, K.-M. Chang, J. Pemberton, A. Sette, and F. V. Chisari Degenerate Immunogenicity of an HLA-A2-Restricted Hepatitis B Virus Nucleocapsid Cytotoxic T-Lymphocyte Epitope That Is Also Presented by HLA-B51 J. Virol., April 15, 2001; 75(8): 3984 - 3987. [Abstract] [Full Text] |
||||
![]() |
T. M. Allen, B. R. Mothé, J. Sidney, P. Jing, J. L. Dzuris, M. E. Liebl, T. U. Vogel, D. H. O'Connor, X. Wang, M. C. Wussow, et al. CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing J. Virol., January 15, 2001; 75(2): 738 - 749. [Abstract] [Full Text] |
||||
![]() |
A. D. Sette, C. Oseroff, J. Sidney, J. Alexander, R. W. Chesnut, K. Kakimi, L. G. Guidotti, and F. V. Chisari Overcoming T Cell Tolerance to the Hepatitis B Virus Surface Antigen in Hepatitis B Virus-Transgenic Mice J. Immunol., January 15, 2001; 166(2): 1389 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Loirat, F. A. Lemonnier, and M.-L. Michel Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization J. Immunol., October 15, 2000; 165(8): 4748 - 4755. [Abstract] [Full Text] [PDF] |
||||
![]() |
S I Khakoo, R Ling, I Scott, A I Dodi, T J Harrison, G M Dusheiko, and J A Madrigal Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals Gut, July 1, 2000; 47(1): 137 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. I. Michalak, P. D. Hodgson, and N. D. Churchill Posttranscriptional Inhibition of Class I Major Histocompatibility Complex Presentation on Hepatocytes and Lymphoid Cells in Chronic Woodchuck Hepatitis Virus Infection J. Virol., May 15, 2000; 74(10): 4483 - 4494. [Abstract] [Full Text] |
||||
![]() |
M. K. Maini, C. Boni, C. K. Lee, J. R. Larrubia, S. Reignat, G. S. Ogg, A. S. King, J. Herberg, R. Gilson, A. Alisa, et al. The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection J. Exp. Med., April 17, 2000; 191(8): 1269 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. V. Chisari Viruses, Immunity, and Cancer: Lessons from Hepatitis B Am. J. Pathol., April 1, 2000; 156(4): 1117 - 1132. [Full Text] [PDF] |
||||
![]() |
G. Lauvau, K. Kakimi, G. Niedermann, M. Ostankovitch, P. Yotnda, H. Firat, F. V. Chisari, and P. M. van Endert Human Transporters Associated with Antigen Processing (Taps) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells J. Exp. Med., November 1, 1999; 190(9): 1227 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kimura, K. Ando, H. Ohnishi, T. Ishikawa, S. Kakumu, M. Takemura, Y. Muto, and H. Moriwaki Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A Int. Immunol., September 1, 1999; 11(9): 1491 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Ishioka, J. Fikes, G. Hermanson, B. Livingston, C. Crimi, M. Qin, M. France del Guercio, C. Oseroff, C. Dahlberg, J. Alexander, et al. Utilization of MHC Class I Transgenic Mice for Development of Minigene DNA Vaccines Encoding Multiple HLA-Restricted CTL Epitopes J. Immunol., April 1, 1999; 162(7): 3915 - 3925. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Livingston, J. Alexander, C. Crimi, C. Oseroff, E. Celis, K. Daly, L. G. Guidotti, F. V. Chisari, J. Fikes, R. W. Chesnut, et al. Altered Helper T Lymphocyte Function Associated with Chronic Hepatitis B Virus Infection and its Role in Response to Therapeutic Vaccination in Humans J. Immunol., March 1, 1999; 162(5): 3088 - 3095. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Chang, N. H. Gruener, S. Southwood, J. Sidney, G. R. Pape, F. V. Chisari, and A. Sette Identification of HLA-A3 and -B7-Restricted CTL Response to Hepatitis C Virus in Patients with Acute and Chronic Hepatitis C J. Immunol., January 15, 1999; 162(2): 1156 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lu, G. Hilken, J. Kruppenbacher, T. Kemper, R. Schirmbeck, J. Reimann, and M. Roggendorf Immunization of Woodchucks with Plasmids Expressing Woodchuck Hepatitis Virus (WHV) Core Antigen and Surface Antigen Suppresses WHV Infection J. Virol., January 1, 1999; 73(1): 281 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishikawa, D. Kono, J. Chung, P. Fowler, A. Theofilopoulos, S. Kakumu, and F. V. Chisari Polyclonality and Multispecificity of the CTL Response to a Single Viral Epitope J. Immunol., December 1, 1998; 161(11): 5842 - 5850. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimizu, L. G. Guidotti, P. Fowler, and F. V. Chisari Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice J. Immunol., November 1, 1998; 161(9): 4520 - 4529. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bertoni, A. Sette, J. Sidney, L. G. Guidotti, M. Shapiro, R. Purcell, and F. V. Chisari Human Class I Supertypes and CTL Repertoires Extend to Chimpanzees J. Immunol., October 15, 1998; 161(8): 4447 - 4455. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Menne, J. Maschke, M. Lu, H. Grosse-Wilde, and M. Roggendorf T-Cell Response to Woodchuck Hepatitis Virus (WHV) Antigens during Acute Self-Limited WHV Infection and Convalescence and after Viral Challenge J. Virol., July 1, 1998; 72(7): 6083 - 6091. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |